nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisacodyl—GPR55—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.204	0.48	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.0239	0.0562	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.0182	0.0428	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.0175	0.0411	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.0135	0.0318	CbGpPWpGaD
Bisacodyl—Anorectal discomfort—Etoposide—peripheral nervous system neoplasm	0.0134	0.0232	CcSEcCtD
Bisacodyl—Abdominal cramps—Vincristine—peripheral nervous system neoplasm	0.0133	0.0232	CcSEcCtD
Bisacodyl—Colitis—Topotecan—peripheral nervous system neoplasm	0.0119	0.0208	CcSEcCtD
Bisacodyl—Colitis—Isotretinoin—peripheral nervous system neoplasm	0.0118	0.0206	CcSEcCtD
Bisacodyl—Colitis—Tretinoin—peripheral nervous system neoplasm	0.0118	0.0206	CcSEcCtD
Bisacodyl—GPR55—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.0118	0.0278	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.0108	0.0253	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.0103	0.0242	CbGpPWpGaD
Bisacodyl—Haematochezia—Epirubicin—peripheral nervous system neoplasm	0.0102	0.0177	CcSEcCtD
Bisacodyl—Haematochezia—Doxorubicin—peripheral nervous system neoplasm	0.0094	0.0164	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00935	0.022	CbGpPWpGaD
Bisacodyl—Colitis—Alitretinoin—peripheral nervous system neoplasm	0.00898	0.0156	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00897	0.0211	CbGpPWpGaD
Bisacodyl—Dehydration—Isotretinoin—peripheral nervous system neoplasm	0.00833	0.0145	CcSEcCtD
Bisacodyl—Dehydration—Tretinoin—peripheral nervous system neoplasm	0.00833	0.0145	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.00819	0.0192	CbGpPWpGaD
Bisacodyl—Cramp muscle—Topotecan—peripheral nervous system neoplasm	0.00813	0.0142	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00781	0.0183	CbGpPWpGaD
Bisacodyl—Anorectal discomfort—Epirubicin—peripheral nervous system neoplasm	0.00748	0.013	CcSEcCtD
Bisacodyl—Abdominal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00742	0.0129	CcSEcCtD
Bisacodyl—Abdominal discomfort—Tretinoin—peripheral nervous system neoplasm	0.00742	0.0129	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.00716	0.0168	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.00709	0.0167	CbGpPWpGaD
Bisacodyl—Anorectal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00693	0.0121	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.00654	0.0154	CbGpPWpGaD
Bisacodyl—Dehydration—Alitretinoin—peripheral nervous system neoplasm	0.00631	0.011	CcSEcCtD
Bisacodyl—Dehydration—Vincristine—peripheral nervous system neoplasm	0.00608	0.0106	CcSEcCtD
Bisacodyl—Immune system disorder—Topotecan—peripheral nervous system neoplasm	0.00564	0.00982	CcSEcCtD
Bisacodyl—Abdominal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00563	0.00979	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.00553	0.013	CbGpPWpGaD
Bisacodyl—Immune system disorder—Melphalan—peripheral nervous system neoplasm	0.00553	0.00962	CcSEcCtD
Bisacodyl—Malnutrition—Topotecan—peripheral nervous system neoplasm	0.00544	0.00947	CcSEcCtD
Bisacodyl—Malnutrition—Isotretinoin—peripheral nervous system neoplasm	0.00539	0.00939	CcSEcCtD
Bisacodyl—Malnutrition—Tretinoin—peripheral nervous system neoplasm	0.00539	0.00939	CcSEcCtD
Bisacodyl—Dehydration—Cisplatin—peripheral nervous system neoplasm	0.00538	0.00937	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.0053	0.0124	CbGpPWpGaD
Bisacodyl—Muscle spasms—Topotecan—peripheral nervous system neoplasm	0.00523	0.0091	CcSEcCtD
Bisacodyl—Cramp muscle—Cisplatin—peripheral nervous system neoplasm	0.00521	0.00907	CcSEcCtD
Bisacodyl—Angioedema—Topotecan—peripheral nervous system neoplasm	0.00497	0.00865	CcSEcCtD
Bisacodyl—Syncope—Tretinoin—peripheral nervous system neoplasm	0.00484	0.00842	CcSEcCtD
Bisacodyl—Syncope—Isotretinoin—peripheral nervous system neoplasm	0.00484	0.00842	CcSEcCtD
Bisacodyl—Abdominal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00479	0.00834	CcSEcCtD
Bisacodyl—Cramp muscle—Etoposide—peripheral nervous system neoplasm	0.00477	0.00831	CcSEcCtD
Bisacodyl—Loss of consciousness—Isotretinoin—peripheral nervous system neoplasm	0.00474	0.00825	CcSEcCtD
Bisacodyl—Loss of consciousness—Tretinoin—peripheral nervous system neoplasm	0.00474	0.00825	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.00463	0.0109	CbGpPWpGaD
Bisacodyl—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00444	0.00773	CcSEcCtD
Bisacodyl—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.0044	0.00766	CcSEcCtD
Bisacodyl—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.0044	0.00766	CcSEcCtD
Bisacodyl—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.00435	0.00758	CcSEcCtD
Bisacodyl—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00435	0.00757	CcSEcCtD
Bisacodyl—Shock—Isotretinoin—peripheral nervous system neoplasm	0.00433	0.00754	CcSEcCtD
Bisacodyl—Shock—Tretinoin—peripheral nervous system neoplasm	0.00433	0.00754	CcSEcCtD
Bisacodyl—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.00432	0.00752	CcSEcCtD
Bisacodyl—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.00432	0.00752	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.0042	0.00988	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.00419	0.00984	CbGpPWpGaD
Bisacodyl—Malnutrition—Alitretinoin—peripheral nervous system neoplasm	0.00409	0.00712	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.00405	0.00951	CbGpPWpGaD
Bisacodyl—Colitis—Epirubicin—peripheral nervous system neoplasm	0.00393	0.00684	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.00386	0.00908	CbGpPWpGaD
Bisacodyl—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.00383	0.00667	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.0038	0.00662	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.0038	0.00662	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00375	0.00653	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.00368	0.00864	CbGpPWpGaD
Bisacodyl—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.00367	0.00638	CcSEcCtD
Bisacodyl—Colitis—Doxorubicin—peripheral nervous system neoplasm	0.00364	0.00633	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00363	0.00632	CcSEcCtD
Bisacodyl—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.00361	0.00629	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.0036	0.00627	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.0036	0.00627	CcSEcCtD
Bisacodyl—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.00359	0.00626	CcSEcCtD
Bisacodyl—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00351	0.00611	CcSEcCtD
Bisacodyl—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.00348	0.00606	CcSEcCtD
Bisacodyl—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00348	0.00606	CcSEcCtD
Bisacodyl—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00348	0.00606	CcSEcCtD
Bisacodyl—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.00335	0.00583	CcSEcCtD
Bisacodyl—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00334	0.00581	CcSEcCtD
Bisacodyl—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.00331	0.00576	CcSEcCtD
Bisacodyl—Shock—Alitretinoin—peripheral nervous system neoplasm	0.00328	0.00572	CcSEcCtD
Bisacodyl—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.00327	0.0057	CcSEcCtD
Bisacodyl—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00327	0.00569	CcSEcCtD
Bisacodyl—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00324	0.00565	CcSEcCtD
Bisacodyl—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00324	0.00565	CcSEcCtD
Bisacodyl—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00322	0.0056	CcSEcCtD
Bisacodyl—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.0032	0.00557	CcSEcCtD
Bisacodyl—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00315	0.00549	CcSEcCtD
Bisacodyl—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.00307	0.00534	CcSEcCtD
Bisacodyl—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00304	0.00529	CcSEcCtD
Bisacodyl—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00301	0.00524	CcSEcCtD
Bisacodyl—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00301	0.00524	CcSEcCtD
Bisacodyl—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00297	0.00518	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00294	0.00512	CcSEcCtD
Bisacodyl—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00293	0.00511	CcSEcCtD
Bisacodyl—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00291	0.00507	CcSEcCtD
Bisacodyl—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00291	0.00507	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.0029	0.00682	CbGpPWpGaD
Bisacodyl—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00288	0.00502	CcSEcCtD
Bisacodyl—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00284	0.00495	CcSEcCtD
Bisacodyl—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00284	0.00495	CcSEcCtD
Bisacodyl—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00282	0.00491	CcSEcCtD
Bisacodyl—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.0028	0.00488	CcSEcCtD
Bisacodyl—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.0028	0.00487	CcSEcCtD
Bisacodyl—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.0028	0.00487	CcSEcCtD
Bisacodyl—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00279	0.00485	CcSEcCtD
Bisacodyl—Headache—Topotecan—peripheral nervous system neoplasm	0.00278	0.00484	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00278	0.00483	CcSEcCtD
Bisacodyl—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00276	0.00481	CcSEcCtD
Bisacodyl—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.00276	0.00481	CcSEcCtD
Bisacodyl—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00276	0.0048	CcSEcCtD
Bisacodyl—Headache—Tretinoin—peripheral nervous system neoplasm	0.00276	0.0048	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00273	0.00475	CcSEcCtD
Bisacodyl—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00265	0.00462	CcSEcCtD
Bisacodyl—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00264	0.00459	CcSEcCtD
Bisacodyl—Nausea—Topotecan—peripheral nervous system neoplasm	0.00264	0.00459	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00263	0.00458	CcSEcCtD
Bisacodyl—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00262	0.00455	CcSEcCtD
Bisacodyl—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00262	0.00455	CcSEcCtD
Bisacodyl—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.0026	0.00453	CcSEcCtD
Bisacodyl—Nausea—Melphalan—peripheral nervous system neoplasm	0.00258	0.00449	CcSEcCtD
Bisacodyl—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.00256	0.00445	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.00255	0.006	CbGpPWpGaD
Bisacodyl—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00254	0.00442	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.00248	0.00583	CbGpPWpGaD
Bisacodyl—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00246	0.00429	CcSEcCtD
Bisacodyl—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00246	0.00428	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00245	0.00427	CcSEcCtD
Bisacodyl—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00237	0.00412	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.00237	0.00556	CbGpPWpGaD
Bisacodyl—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00229	0.00398	CcSEcCtD
Bisacodyl—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00228	0.00397	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00225	0.00391	CcSEcCtD
Bisacodyl—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00221	0.00384	CcSEcCtD
Bisacodyl—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.0022	0.00383	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.00217	0.0051	CbGpPWpGaD
Bisacodyl—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00214	0.00372	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00213	0.00371	CcSEcCtD
Bisacodyl—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00213	0.0037	CcSEcCtD
Bisacodyl—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00212	0.00369	CcSEcCtD
Bisacodyl—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00209	0.00365	CcSEcCtD
Bisacodyl—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00209	0.00364	CcSEcCtD
Bisacodyl—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00206	0.00358	CcSEcCtD
Bisacodyl—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00204	0.00356	CcSEcCtD
Bisacodyl—Headache—Vincristine—peripheral nervous system neoplasm	0.00201	0.00351	CcSEcCtD
Bisacodyl—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00198	0.00345	CcSEcCtD
Bisacodyl—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00195	0.00339	CcSEcCtD
Bisacodyl—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00192	0.00334	CcSEcCtD
Bisacodyl—Nausea—Vincristine—peripheral nervous system neoplasm	0.00191	0.00332	CcSEcCtD
Bisacodyl—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.00186	0.00323	CcSEcCtD
Bisacodyl—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00181	0.00315	CcSEcCtD
Bisacodyl—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.00179	0.00311	CcSEcCtD
Bisacodyl—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00178	0.0031	CcSEcCtD
Bisacodyl—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00172	0.003	CcSEcCtD
Bisacodyl—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.00172	0.00299	CcSEcCtD
Bisacodyl—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00172	0.00299	CcSEcCtD
Bisacodyl—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00169	0.00294	CcSEcCtD
Bisacodyl—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00166	0.00288	CcSEcCtD
Bisacodyl—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.00166	0.00288	CcSEcCtD
Bisacodyl—Headache—Etoposide—peripheral nervous system neoplasm	0.00163	0.00284	CcSEcCtD
Bisacodyl—Syncope—Epirubicin—peripheral nervous system neoplasm	0.0016	0.00279	CcSEcCtD
Bisacodyl—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.00159	0.00277	CcSEcCtD
Bisacodyl—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.00157	0.00274	CcSEcCtD
Bisacodyl—Nausea—Etoposide—peripheral nervous system neoplasm	0.00155	0.00269	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.00154	0.00361	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.00151	0.00355	CbGpPWpGaD
Bisacodyl—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.00148	0.00258	CcSEcCtD
Bisacodyl—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00146	0.00254	CcSEcCtD
Bisacodyl—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.00145	0.00253	CcSEcCtD
Bisacodyl—Shock—Epirubicin—peripheral nervous system neoplasm	0.00144	0.0025	CcSEcCtD
Bisacodyl—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.00143	0.00249	CcSEcCtD
Bisacodyl—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00135	0.00235	CcSEcCtD
Bisacodyl—Shock—Doxorubicin—peripheral nervous system neoplasm	0.00133	0.00231	CcSEcCtD
Bisacodyl—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00132	0.00231	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00126	0.00219	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.00119	0.00208	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.00119	0.0028	CbGpPWpGaD
Bisacodyl—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00117	0.00203	CcSEcCtD
Bisacodyl—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00115	0.00201	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.00112	0.00264	CbGpPWpGaD
Bisacodyl—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.0011	0.00192	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.00109	0.00257	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.00108	0.00254	CbGpPWpGaD
Bisacodyl—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00108	0.00187	CcSEcCtD
Bisacodyl—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.00107	0.00186	CcSEcCtD
Bisacodyl—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000999	0.00174	CcSEcCtD
Bisacodyl—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000995	0.00173	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000992	0.00233	CbGpPWpGaD
Bisacodyl—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000965	0.00168	CcSEcCtD
Bisacodyl—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000928	0.00162	CcSEcCtD
Bisacodyl—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000924	0.00161	CcSEcCtD
Bisacodyl—Headache—Epirubicin—peripheral nervous system neoplasm	0.000915	0.00159	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000907	0.00213	CbGpPWpGaD
Bisacodyl—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000893	0.00156	CcSEcCtD
Bisacodyl—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000867	0.00151	CcSEcCtD
Bisacodyl—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000859	0.0015	CcSEcCtD
Bisacodyl—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000846	0.00147	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000845	0.00199	CbGpPWpGaD
Bisacodyl—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000802	0.0014	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.000694	0.00163	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000664	0.00156	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—AKT1—peripheral nervous system neoplasm	0.000586	0.00138	CbGpPWpGaD
